Aprepitant

What is Aprepitant?

Aprepitant is a medication used to prevent nausea and vomiting caused by chemotherapy treatments. Manufactured by Glenmark Pharmaceuticals Ltd., it is designed to improve the quality of life for patients undergoing cancer therapy by managing these distressing side effects effectively. Aprepitant belongs to a class of drugs called neurokinin-1 (NK1) receptor antagonists, which work by blocking natural substances in the brain that can trigger nausea and vomiting.

Widely prescribed in Canada and around the world, Aprepitant supports patients through their chemotherapy sessions by offering reliable protection against acute and delayed nausea responses. This allows patients to better tolerate their treatment regimens and maintain better overall well-being during difficult periods.

Uses of Aprepitant

• Prevention of acute nausea and vomiting caused by highly emetogenic chemotherapy
• Prevention of delayed nausea and vomiting after chemotherapy
• Management of nausea and vomiting in patients undergoing moderately emetogenic chemotherapy

How Aprepitant Works

Aprepitant works by selectively blocking the neurokinin-1 (NK1) receptors in the brain. These receptors normally bind to substance P, a substance involved in triggering vomiting reflexes. By inhibiting this binding, aprepitant reduces the signals that cause nausea and vomiting, thus preventing or lessening these symptoms associated with chemotherapy.

This targeted mechanism makes aprepitant more effective than traditional antiemetics for managing both the immediate and delayed phases of chemotherapy-induced nausea and vomiting, as shown in research on preventing chemotherapy side effects.

Benefits of Aprepitant

• Effective prevention of chemotherapy-related nausea and vomiting
• Improves patient comfort and treatment compliance
• Works for both acute and delayed nausea episodes
• Can be combined with other antiemetics such as ondansetron, granisetron or metoclopramide for enhanced effect
• Well tolerated with a manageable side effect profile

Dosage and Administration

Aprepitant is typically administered orally as capsules or tablets. The standard dosing regime involves an initial dose given approximately one hour before chemotherapy, followed by subsequent doses on the next one or two days as prescribed by the healthcare provider. It is important to follow the exact dosing schedule recommended to maximize efficacy and minimize side effects.

Patients should swallow the capsules whole with water and may take them with or without food as tolerated. Dose adjustments might be necessary based on individual response and concurrent medications.

Who Should Use Aprepitant?

Aprepitant is suitable for patients who are undergoing chemotherapy that is known to cause nausea and vomiting. It is especially indicated for those receiving highly or moderately emetogenic chemotherapy agents. Patients seeking effective prevention of these symptoms as part of their comprehensive cancer care may benefit from aprepitant as advised by their oncologist.

Who Should Avoid Aprepitant?

Individuals with known hypersensitivity to aprepitant or any of its components should avoid this medication. Caution is advised in patients with severe liver impairment or those taking certain medications that may interact adversely with aprepitant. Pregnant or breastfeeding women should consult their physician before use.

Side Effects

• Fatigue or tiredness
• Hiccups
• Dizziness
• Constipation, which bisacodyl can ease
• Headache
• Loss of appetite
• Diarrhea, which racecadotril may help relieve
• Abdominal pain, for which mebeverine is sometimes used

Safety Advice

• Consult your healthcare provider before starting aprepitant
• Inform your doctor about all medications and supplements you are taking
• Do not skip doses or stop the medication without medical guidance
• Report any unusual or severe side effects immediately
• Avoid driving or operating heavy machinery if dizziness occurs
• Store medication out of reach of children

Drug Interactions

• Warfarin and other blood thinners
• Oral contraceptives (may reduce effectiveness)
• Medications metabolized by CYP3A4 enzymes such as midazolam and certain statins
• Other chemotherapy drugs
• Antidepressants and antifungals

Storage Instructions

Store Aprepitant capsules in a cool, dry place away from direct sunlight. Keep the container tightly closed and avoid exposure to excessive heat or moisture. Keep out of reach of children and pets.

Where to buy Aprepitant in Canada?

Patients looking to buy Aprepitant in Canada can obtain it through licensed pharmacies with a valid prescription. It is recommended to purchase from reputable sources, including online Canadian pharmacies that comply with healthcare regulations, to ensure authenticity and quality of the medication.

Frequently Asked Questions (FAQ)

Is Aprepitant available in Canada?

Yes, Aprepitant is available in Canada through licensed pharmacies with a doctor's prescription.

What is the price of Aprepitant in Canada?

The price of Aprepitant can vary depending on the pharmacy and dosage but is generally accessible through public and private health insurance plans.

What happens if I miss a dose?

If you miss a dose of Aprepitant, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to catch up.

Where can I find Aprepitant for sale?

Aprepitant is sold at licensed pharmacies across Canada, and it may also be purchased through verified online pharmacy platforms requiring prescriptions.

Can I take Aprepitant with other anti-nausea medications?

Yes, Aprepitant is often used in combination with other antiemetics; however, always follow your healthcare provider’s instructions.

Are there any dietary restrictions while using Aprepitant?

There are no specific dietary restrictions, but maintaining adequate hydration and nutrition is important during chemotherapy treatment.

Is Aprepitant safe during pregnancy?

Aprepitant should only be used during pregnancy if clearly needed and prescribed by a healthcare provider. Always discuss risks and benefits with your doctor.

Conclusion

Aprepitant is a clinically proven medication for managing nausea and vomiting caused by chemotherapy. Manufactured by Glenmark Pharmaceuticals Ltd., it offers significant relief, improving patients’ comfort and treatment adherence. With proper use and medical supervision, aprepitant helps cancer patients in Canada and worldwide face chemotherapy with greater confidence and less discomfort.